Literature DB >> 7634808

Soluble tumor necrosis factor receptors reduce bowel ischemia-induced lung permeability and neutrophil sequestration.

P Sorkine1, A Setton, P Halpern, A Miller, V Rudick, S Marmor, J M Klausner, G Goldman.   

Abstract

OBJECTIVES: To evaluate the possible role of tumor necrosis factor (TNF) in the development of lung injury after bowel ischemia, and the ability of TNF-soluble receptors to negate TNF toxicity, using a rat small bowel ischemia and reperfusion model.
DESIGN: Prospective, randomized, controlled laboratory study.
SETTING: Research laboratory.
SUBJECTS: Forty adult male Sprague-Dawley rats weighing approximately 300 g.
INTERVENTIONS: The rats were divided equally into four groups: a) ischemia and reperfusion alone; b) those animals receiving TNF antibodies (1 mL) before reperfusion; and c) those animals receiving 200 micrograms of human recombinant TNF soluble receptors. These 30 anesthetized rats underwent 60 mins of superior mesenteric artery occlusion per 4 hrs of reperfusion. The remaining ten animals were sham operated (laparotomy), serving as controls. Lung permeability was measured using bovine serum albumin labeled with 125I, and organ injury was assessed histologically.
MEASUREMENTS AND MAIN RESULTS: Thirty and 60 mins after declamping and reperfusion, plasma TNF concentrations increased to 830 +/- 66 and 173 +/- 56 pg/mL, respectively, compared with 10 pg/mL before ischemia (p < .001). In sham-operated control rats, TNF concentrations did not increase from baseline concentrations. Four hours after reperfusion, sequestration of neutrophils in the pulmonary microcirculation was noted (319 +/- 60 vs. 84 +/- 13 neutrophils/10 high-power fields in sham-operated rats [p < .04]). Pulmonary microvascular leak also occurred, as measured by translocation of radiolabeled albumin into the bronchoalveolar space and expressed as the ratio of bronchoalveolar lavage to blood concentrations. This ratio was 5.3 +/- 0.8 in ischemic control animals compared with 1.1 +/- 0.3 in sham animals (p < .03). Treatment with antibodies to TNF before reperfusion attenuated the pulmonary injury (75 +/- 6 neutrophils/10 high-power fields, permeability index 1.6 +/- 0.1) less than in ischemic controls (p < .005). A similar protection was achieved with soluble TNF receptors, which prevented bowel ischemia-induced lung neutrophil sequestration (117 +/- 35 neutrophils/10 high-power fields, pulmonary vascular leak ratio of 2.3 +/- 0.1, p < .05).
CONCLUSIONS: The results of this study show that ischemia and subsequent reperfusion of the intestine in rats produce lung injury. This injury is mediated, at least in part, by TNF. Soluble TNF receptors are an effective tool in preventing lung TNF injury after intestinal ischemia.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7634808     DOI: 10.1097/00003246-199508000-00011

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  17 in total

1.  Effects of inhibition of PDE4 and TNF-alpha on local and remote injuries following ischaemia and reperfusion injury.

Authors:  D G Souza; G D Cassali; S Poole; M M Teixeira
Journal:  Br J Pharmacol       Date:  2001-11       Impact factor: 8.739

2.  Increased mortality and inflammation in tumor necrosis factor-stimulated gene-14 transgenic mice after ischemia and reperfusion injury.

Authors:  Danielle G Souza; Adriana C Soares; Vanessa Pinho; Humberto Torloni; Luiz F L Reis; Mauro M Teixeira; Adriana A M Dias; Mauro T Martins
Journal:  Am J Pathol       Date:  2002-05       Impact factor: 4.307

3.  Tempol prevents harmful effects of remote ischemia reperfusion injury on healing of experimental colonic anastomoses.

Authors:  Cagatay Aydin; Zafer Teke; Faruk Aytekin; Cigdem Yenisey; Burhan Kabay; Nilufer Genc Simsek; Koray Tekin
Journal:  Int J Colorectal Dis       Date:  2006-05-23       Impact factor: 2.571

4.  Local and remote tissue injury upon intestinal ischemia and reperfusion depends on the TLR/MyD88 signaling pathway.

Authors:  Tatiana Victoni; Fernando Rodrigues Coelho; Alexandre Learth Soares; Andressa de Freitas; Thomas Secher; Rodrigo Guabiraba; François Erard; Ricardo Martins de Oliveira-Filho; B Boris Vargaftig; Gregoire Lauvaux; Mamdouh A Kamal; Bernhard Ryffel; René Moser; Wothan Tavares-de-Lima
Journal:  Med Microbiol Immunol       Date:  2009-11-26       Impact factor: 3.402

5.  Pyrrolidine dithiocarbamate prevents deleterious effects of remote ischemia/reperfusion injury on healing of colonic anastomoses in rats.

Authors:  Zafer Teke; Faruk Onder Aytekin; Burhan Kabay; Cigdem Yenisey; Cagatay Aydin; Koray Tekin; Mustafa Sacar; Akin Ozden
Journal:  World J Surg       Date:  2007-09       Impact factor: 3.352

6.  Comparative anti-inflammatory activities of antagonists to C3a and C5a receptors in a rat model of intestinal ischaemia/reperfusion injury.

Authors:  Lavinia M Proctor; Thiruma V Arumugam; Ian Shiels; Robert C Reid; David P Fairlie; Stephen M Taylor
Journal:  Br J Pharmacol       Date:  2004-05-24       Impact factor: 8.739

7.  Lung injury after in vivo reperfusion: outcome at 27 hours after reperfusion.

Authors:  Idit Matot; Sharon Einav; Carolyn F Weiniger; Ron G Pearl; Rinat Abramovitch; Balachandra V Joshi; Kenneth A Jacobson
Journal:  Anesthesiology       Date:  2008-08       Impact factor: 7.892

8.  Protective effects of hyperbaric oxygen and iloprost on ischemia/reperfusion-induced lung injury in a rabbit model.

Authors:  S Bozok; G Ilhan; Y Yilmaz; Z Dökümcü; L Tumkaya; H Karamustafa; S Ozan Karakisi; S Ergene; E Sener
Journal:  Eur J Med Res       Date:  2012-06-07       Impact factor: 2.175

9.  Transduced PEP-1-heme oxygenase-1 fusion protein reduces remote organ injury induced by intestinal ischemia/reperfusion.

Authors:  Xiang-Hu He; Qing-Wen Li; Yan-Lin Wang; Zong-Ze Zhang; Jian-Juan Ke; Xue-Tao Yan; Kai Chen
Journal:  Med Sci Monit       Date:  2015-04-12

10.  The Receptor for Advanced Glycation Endproducts Does Not Contribute to Pathology in a Mouse Mesenteric Ischemia/Reperfusion-Induced Injury Model.

Authors:  Mike C L Wu; Timothy D Gilmour; Susanna Mantovani; Trent M Woodruff
Journal:  Front Immunol       Date:  2015-12-07       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.